Author

Lorant Gonczi 1

1 Semmelweis University,Budapest,Hungary

Benefits of implementing a rapid access clinic in a high volume inflammatory bowel disease center: access, resource utilization and outcomes

Sofia Nene, Lorant Gonczi, Christine Verdon, Jason Reinglas, Rita Kohen, Talat Bessissow, Waqqas Afif, Gary Wild, Ernest Seidman, Alain Bitton, Peter L Lakatos

CHANGES IN THERAPEUTIC STRATEGY AND OUTCOMES IN NEWLY DIAGNOSED PATIENT WITH CROHN’S DISEASE IN THE BIOLOGICAL ERA IN HUNGARY: A NATIONWIDE STUDY BASED ON THE NATIONAL HEALTH INSURANCE FUND DATABASE

Zsuzsanna Kürti, Lorant Gonczi, Zsuzsanna Vegh, Petra Anna Golovics, Petra Fadgyas-Freyler, Judit Gimesi-Országh, Gyula Korponai, Barbara Dorottya Lovasz, Krisztina Barbara Gecse, Peter L Lakatos

PREDICTORS OF LOSS OF RESPONSE TO ADALIMUMAB THERAPY; THE IMPORTANCE OF THERAPEUTIC DRUG MONITORING IN INFLAMMATORY BOWEL DISEASES

Zsuzsanna Kürti, Zsuzsanna Vegh, Mariann Rutka, Lorant Gonczi, Klaudia Farkas, Barbara Dorottya Lovasz, Krisztina Barbara Gecse, Petra Anna Golovics, Balazs Szalay, Tamás Molnár, Peter L Lakatos

FINAL RESULTS ON EFFICACY AND SAFETY OF BIOSIMILAR INFLIXIMAB AFTER ONE-YEAR: RESULTS FROM A PROSPECTIVE NATIONWIDE COHORT

Krisztina Barbara Gecse, Zsuzsanna Vegh, Zsuzsanna Kürti, Mariann Rutka, Klaudia Farkas, Petra Anna Golovics, Barbara Dorottya Lovasz, Lorant Gonczi, János Banai, László Bene, Beata Gasztonyi, Tünde Kristóf, László Lakatos, Pal Miheller, Ferenc Nagy, Karoly Palatka, Mária Papp, Árpád V. Patai, Ágnes Szabone Salamon, Tamá

QUALITY OF CARE AND OUTCOMES IN A TERTIARY HOSPITAL INFLAMMATORY BOWEL DISEASE (IBD) CENTER: MONITORING AND TREATMENT ALGORITHMS AT REFERRAL AND DURING FOLLOW-UP

Sophie Restellini, Sofia Nene, Rita Kohen, Lorant Gonczi, Zsuzsanna Kürti, Waqqas Afif, Talat Bessissow, Gary Wild, Ernest Seidman, Alain Bitton, Peter L Lakatos

Surgery and hospitalization rates in Inflammatory Bowel Disease patients in the Québec provincial database from 1996 - 2015

Christine Verdon, Jason Reinglas, Janie Coulombe, Lorant Gonczi, Talat Bessissow, Waqqas Afif, Maria Vutcovici, Gary Wild, Ernest Seidman, Alain Bitton, Paul Brassard, Peter L Lakatos

FINAL RESULTS ON IMMUNOGENICITY PROFILE AND PREDICTORS OF ADA DEVELOPMENT OF BIOSIMILAR INFLIXIMAB DURING THE FIRST 12 MONTHS OF THE THERAPY: RESULTS FROM A PROSPECTIVE NATIONWIDE COHORT

Petra Anna Golovics, Barbara Dorottya Lovasz, Zsuzsanna Kürti, Mariann Rutka, Zsuzsanna Vegh, Krisztina Barbara Gecse, Klaudia Farkas, János Banai, László Bene, Lorant Gonczi, Beata Gasztonyi, Tünde Kristóf, László Lakatos, Pal Miheller, Karoly Palatka, Árpád V. Patai, Mária Papp, Ágnes Szabone Salamon, Tamás Szamosi, Zo

QUALITY OF CARE AND OUTCOMES IN A TERTIARY HOSPITAL INFLAMMATORY BOWEL DISEASE (IBD) CENTER: MONITORING AND TREATMENT ALGORITHMS AT REFERRAL AND DURING FOLLOW-UP

Lorant Gonczi

Item 1 - 8 / 8
1